Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways.

The Journal of Biological Chemistry
Soichiro S ItoTadaaki Kirita

Abstract

The anticancer agent 5-fluorouracil (5-FU) is cytotoxic and often used to treat various cancers. 5-FU is thought to inhibit the enzyme thymidylate synthase, which plays a role in nucleotide synthesis and has been found to induce single- and double-strand DNA breaks. ATR Ser/Thr kinase (ATR) is a principal kinase in the DNA damage response and is activated in response to UV- and chemotherapeutic drug-induced DNA replication stress, but its role in cellular responses to 5-FU is unclear. In this study, we examined the effect of ATR inhibition on 5-FU sensitivity of mammalian cells. Using immunoblotting, we found that 5-FU treatment dose-dependently induced the phosphorylation of ATR at the autophosphorylation site Thr-1989 and thereby activated its kinase. Administration of 5-FU with a specific ATR inhibitor remarkably decreased cell survival, compared with 5-FU treatment combined with other major DNA repair kinase inhibitors. Of note, the ATR inhibition enhanced induction of DNA double-strand breaks and apoptosis in 5-FU-treated cells. Using gene expression analysis, we found that 5-FU induced the activation of the intra-S cell-cycle checkpoint. Cells lacking BRCA2 were sensitive to 5-FU in the presence of ATR inhibitor. Moreover...Continue Reading

References

Jan 1, 1992·Cytometry·Z DarzynkiewiczF Traganos
Sep 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·T Lindahl
Aug 1, 1997·Molecular and Cellular Biology·V V OgryzkoB H Howard
Dec 23, 1998·Trends in Cell Biology·R KanaarD C van Gent
Mar 19, 1999·Cytometry·E BednerZ Darzynkiewicz
Dec 3, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·G FangM W Kirschner
Aug 12, 2000·International Journal of Oncology·H KanataH Hosoi
May 30, 2001·Mutation Research·L H Thompson, D Schild
May 23, 2002·Carcinogenesis·Stephen P Jackson
Nov 26, 2002·Molecular and Cellular Biology·Timothy P HeffernanWilliam K Kaufmann
Jan 16, 2003·Cell·Anne M CasperThomas W Glover
Feb 5, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S J WelshG W Aherne
May 2, 2003·Nature Reviews. Cancer·Daniel B LongleyPatrick G Johnston
Aug 5, 2003·Molecular and Cellular Biology·Kai RothkammMarkus Löbrich
Sep 1, 2005·Cancer Letters·Akihisa Takahashi, Takeo Ohnishi
Jan 25, 2006·The Journal of Biological Chemistry·Jeremy S Myers, David Cortez
May 15, 2007·Cell Cycle·Edward T PetriRavi Basavappa
Aug 31, 2007·Biostatistics·Mark D Robinson, Gordon K Smyth
Dec 19, 2007·Cell Research·Helena Lobo BorgesJean Y J Wang
Sep 4, 2008·Mutation Research·Akihisa TakahashiTakeo Ohnishi
Nov 4, 2008·Cellular and Molecular Life Sciences : CMLS·M D Wyatt, D M Wilson
Jul 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xiao-Peng ZhangWei Wang
Sep 25, 2009·British Journal of Pharmacology·Long Shan LiDavid A Boothman
Nov 3, 2010·Advances in Cancer Research·Joanne SmithDavid A Gillespie
Jul 23, 2011·Molecular Cell·Shizhou LiuLee Zou
Jul 11, 2012·Obstetrics and Gynecology·Kasmintan A SchraderJessica N McAlpine
Aug 7, 2012·Cellular and Molecular Life Sciences : CMLS·Anna S NikonovaErica A Golemis
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Feb 6, 2013·Cancer Biology & Therapy·Derek Woods, John J Turchi
Jul 3, 2013·Cold Spring Harbor Perspectives in Biology·Bianca M Sirbu, David Cortez
Sep 5, 2013·Cold Spring Harbor Perspectives in Biology·Alexandre Maréchal, Lee Zou
Jan 1, 2010·Cancers·Koh MiuraIwao Sasaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis